Assessment of the aggregate index of systemic inflammation in dyslipidemia with dry eye disease: a retrospective case-control

• by Amani Y. Alhalwani, Asma Altasan, Nawaf Alasmari, Asma Almutiri, Mustafa Sunbul, Razan Khalifa, Jumanah Makhtoum, Shatha Jambi

• June 11, 2026

The Hormonal Link to Ocular Disease in Women

Neda Gioia, OD, CNS, FMCP, FOWNS, reviewed how levels of individual hormones and the balance between them help regulate tear production, inflammation, wound healing, lipid secretion, intraocular pressure (IOP), and neuroprotection, and therefore can result in a higher burden of dry eye, glaucoma, or retinal disease in women.

• by Veronica Daub

• June 17, 2026

• 5 min

Integrated management of dry eye–depression comorbidity: mechanistic insights and temporal therapeutic strategies

• by Te-du Yang, Chuan-long Wu, Xiao-juan Li, Shao-rong Hu, Jing Zang

• June 2, 2026

CSO Meeting 2026 Highlights Convergence of Innovation and Clinical Practice

More than 300 professionals gathered for three days of innovation, education, and collaboration, highlighting the latest advances in ophthalmic technology and clinical practice

• May 12, 2026

• 2 min